• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24649 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2025     WorkSafeBC Tower crane operators and low back pain
2025     WorkSafeBC Firefighting and Crohn’s disease
2025     WorkSafeBC Aerolase® System in treating burn/scar tissue
2025     WorkSafeBC IV ketamine therapy for long Covid
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Regulation and clinical prioritization processes for the optimal deployment of a helicopter emergency medical transport system in Quebec]
2025     The Regional Health Technology Assessment Centre (HTA-centrum) Maternal and perinatal mortality and severe morbidity of midwife assisted births outside hospital compared with hospital births
2025     The Regional Health Technology Assessment Centre (HTA-centrum) Dental assessment for prevention of medication-related osteonecrosis of the jaw in adults with early breast cancer
2025     Austrian Institute for Health Technology Assessment (AIHTA) Obecabtagene autoleucel (AUCATZYL®) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia
2025     Austrian Institute for Health Technology Assessment (AIHTA) Social prescribing in primary care. Development of an Austrian programme theory based on realist evidence
2025     Austrian Institute for Health Technology Assessment (AIHTA) Further development of the programme on preventive medical check-ups in Austria. Risk scores for cardiovascular disease: a systematic review
2025     Austrian Institute for Health Technology Assessment (AIHTA) Further development of the programme on preventive health check-ups in Austria. Brief interventions for lifestyle counselling: umbrella review and qualitative survey
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Antibiotic prophylaxis in digestive tract and abdominal wall surgery]
2025     National Institute for Health and Care Excellence (NICE) VA ECMO for postcardiotomy cardiogenic shock in adults. NICE interventional procedures guidance 810
2025     National Institute for Health and Care Excellence (NICE) Talquetamab for treating relapsed and refractory multiple myeloma after 3 or more treatments. NICE technology appraisal guidance 1114
2025     National Institute for Health and Care Excellence (NICE) Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse large B-cell lymphoma. NICE technology appraisal guidance 1113
2025     National Institute for Health and Care Excellence (NICE) Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy. NICE technology appraisal guidance 1115
2025     National Institute for Health and Care Excellence (NICE) Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemia. NICE technology appraisal guidance 1116
2025     National Institute for Health and Care Excellence (NICE) Dostarlimab with platinum-containing chemotherapy for treating primary advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency. NICE technology appraisal guidance 1117
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of prescription opioids for pain in Quebecers aged 65 years and older]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acalabrutinib (mantle cell lymphoma; combination with bendamustine and rituximab) – Addendum to Project A25-89]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (oesophageal or gastro-oesophageal junction cancer, adjuvant) – Addendum to Project A25-88]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (colorectal cancer with dMMR or MSI-H, first line, combination with ipilimumab) – Addendum to Project A25-80]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Resmetirom (metabolic dysfunction-associated steatohepatitis) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Avacopan (granulomatosis with polyangiitis or microscopic polyangiitis) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evaluation of the relevance of Embase for searches for drug trials]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bulevirtide (chronic hepatitis D) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tisotumab vedotin (cervical cancer) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lecanemab (early Alzheimer’s disease) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guselkumab (ulcerative colitis) – Addendum to Project A25-74]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guselkumab (Crohn’s disease) – Addendum to Project A25-75]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Datopotamab deruxtecan (breast cancer) – Addendum to Project A25-69]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asciminib (chronic myeloid leukaemia) – Addendum to Project A25-70]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acalabrutinib (previously untreated chronic lymphocytic leukaemia; combination with venetoclax and obinutuzumab) – Addendum to Project A25-91]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acalabrutinib (previously untreated chronic lymphocytic leukaemia; combination with venetoclax) – Addendum to Project A25-85]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acalabrutinib (mantle cell lymphoma; combination with bendamustine and rituximab) – Second addendum to Project A25-89]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acalabrutinib (mantle cell lymphoma; monotherapy) – Addendum to Project A25-90]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Onasemnogene abeparvovec (spinal muscular atrophy): Review of the study protocol (Version 5.01) and statistical analysis plan (Version 5.01) – Sixth addendum to Project A20-61]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Artificial intelligence in medical imaging: fields of application and considerations for its deployment in Quebec]
2025     Austrian Institute for Health Technology Assessment (AIHTA) Enfortumab vedotin in combination with pembrolizumab in urothelial cancer
2025     Austrian Institute for Health Technology Assessment (AIHTA) Transition from child and adolescent to adult mental health services: analysis of international models and recommendations for action for Austria
2025     HTA Region Stockholm [Therapeutic benefits and adverse effects of extended idebenone treatment in Leber hereditary optic neuropathy (LHON)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [RT-qPCR monitoring of NPM1 variants for measurable residual disease in acute myeloid leukemia]
2025     NIHR Health Services and Delivery Research programme Integration of specialised services for eating disorders and functional symptom disorders in children and young people: discrete choice experiments and qualitative study
2025     NIHR Health Technology Assessment programme Cost-effectiveness of endoscopic treatments for obesity: a clinical evidence map and systematic review to inform a model-based cost-effectiveness analysis
2025     NIHR Health Technology Assessment programme A community-based rehabilitation package following hip fracture: FEMuR III a multi-centre RCT, economic and process evaluation
2025     NIHR Health Technology Assessment programme Tele-ophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease: HERMES cluster randomised trial with a diagnostic accuracy study
2025     NIHR Health Services and Delivery Research programme Witness to harm-holding to account. Improving patient, family and colleague experiences of fitness to practise proceedings: a mixed-methods study
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [The safety, efficacy, effectiveness, efficiency, and organizational impact of mHealth tools for guided telerehabilitation that enable telemonitoring in neck pain, low back pain, and painful shoulder]
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Patient-specific 3D-printed models in surgical planning: mapping review of clinical indications and scoping review of organizational and legal aspects]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Relevance of the use of HIV rapid test kits by community workers in Québec]
2025     NIHR Health Technology Assessment programme Process evaluation exploring implementation and delivery of a home-based extended exercise intervention for older people with frailty: the HERO trial
2025     Haute Autorite de sante (HAS) [Targeted next-generation sequencing of gene panels for the pharmacogenetics of acute leukaemia and supportive care treatments.]
2025     Malaysian Health Technology Assessment (MaHTAS) Robotic-assisted surgery for gynaecological disorders
2025     Malaysian Health Technology Assessment (MaHTAS) Apomorphine injection and subcutaneous infusion therapy for advanced Parkinson’s disease
2025     Malaysian Health Technology Assessment (MaHTAS) Microwave ablation for kidney and liver tumours
2025     Malaysian Health Technology Assessment (MaHTAS) 3D-printing for orthosis, prosthesis and exoskeleton
2025     Malaysian Health Technology Assessment (MaHTAS) Laparoscopic indocyanine green sentinel lymph node mapping in endometrial cancer
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Principles and criteria to guide the use of whole-genome sequencing versus targeted gene sequencing for the detection of somatic variants in oncology]
2025     Haute Autorite de sante (HAS) [Second-line non-invasive skin imaging techniques, including in vivo reflectance confocal microscopy (RCM), for the diagnosis and preoperative mapping of melanoma]
2025     NIHR Health Services and Delivery Research programme Health visiting in the UK in light of the COVID-19 pandemic experience (RReHOPE): study synopsis
2025     NIHR Health Technology Assessment programme Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews
2025     NIHR Health Technology Assessment programme Optimal provision of opiate substitution therapy and needle and syringe programmes: a multi-method realist evaluation
2025     NIHR Health Technology Assessment programme Compression Hosiery to Avoid the Post-Thrombotic Syndrome: a synopsis of the CHAPS RCT
2025     NIHR Health Services and Delivery Research programme Proactive integrated consultation-liaison psychiatry for older medical inpatients: The HOME Study RCT of its effectiveness and cost-effectiveness
2025     NIHR Health Technology Assessment programme Accuracy and clinical effectiveness of fetal growth monitoring strategies for the prediction of small for gestational age at birth: a systematic review and meta-analysis
2025     NIHR Health Technology Assessment programme Behavioural weight management interventions for the treatment of obesity: network meta-analysis of trial and real-world individual participant data
2025     NIHR Health Technology Assessment programme Dismantling behavioural weight management interventions: component network meta-analysis of randomised controlled trials and real-world services
2025     NIHR Health Technology Assessment programme Risk assessment tools for predicting transfusion in surgery: a systematic review and meta-analysis
2025     NIHR Health Services and Delivery Research programme Developing palliative and end-of-life care research partnerships in the North East and North Cumbria: a report on the first year of the RIPEN network
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Next-generation medical devices: the rise of artificial intelligence]
2025     The Danish Health Technology Council (DHTC) [Evaluation report concerning supervised walking exercise for patients with intermittent claudication]
2025     The Danish Health Technology Council (DHTC) [Evaluation report concerning HAL-Guided transurethral resection of bladder tumors in adult patients with suspected non-muscle-invasive bladder cancer]
2025     The Danish Health Technology Council (DHTC) [Evaluation report concerning endovascular treatment of abdominal aortic aneurysms without rupture]
2025     The Danish Health Technology Council (DHTC) [Evaluation report concerning the SelfBack app for the treatment of non-specific low back pain]
2025     The Danish Health Technology Council (DHTC) [Analysis report on the management of persistent symptoms following meniscal injury]
2025     The Danish Health Technology Council (DHTC) [The use of point of care tests (POCT) for elderly patients at home]
2025     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of the safety, efficacy, effectiveness, and economic impact of birth centers as an alternative to low-risk delivery care (at the onset of labor) in a hospital setting]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Cardiac ultrasound: current practices]
2025     National Institute for Health and Care Excellence (NICE) Low-energy contact X-ray brachytherapy for rectal cancer. NICE interventional procedures guidance 809
2025     National Institute for Health and Care Excellence (NICE) Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer. NICE technology appraisal guidance 1108
2025     National Institute for Health and Care Excellence (NICE) Delgocitinib for treating moderate to severe chronic hand eczema. NICE technology appraisal guidance 1107
2025     National Institute for Health and Care Excellence (NICE) Cabotegravir for preventing HIV-1 in adults and young people. NICE technology appraisal guidance 1106
2025     National Institute for Health and Care Excellence (NICE) Darolutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer. NICE technology appraisal guidance 1109
2025     National Institute for Health and Care Excellence (NICE) Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (terminated appraisal). NICE technology appraisal guidance 1111
2025     National Institute for Health and Care Excellence (NICE) Trastuzumab deruxtecan for treating hormone receptor-positive HER2-low metastatic breast cancer after 2 or more endocrine treatments (terminated appraisal). NICE technology appraisal guidance 1112
2025     National Institute for Health and Care Excellence (NICE) Abiraterone (originator and generics) for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer. NICE technology appraisal guidance 1110
2025     NIHR Health Technology Assessment programme Brief psychodynamic-interpersonal therapy for adults with a history of self-harm: the SafePIT RCT
2025     Penn Medicine Center for Evidence-based Practice (CEP) Tools for predicting imminent death
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Blood determination of N-terminal propeptide of procollagen type 1 (P1NP) by electrochemiluminescence immunoassay (ECLIA)]
2025     Adelaide Health Technology Assessment (AHTA) Newborn bloodspot screening for glycogen storage disease, Type II (GSD II; Pompe disease)
2025     Adelaide Health Technology Assessment (AHTA) Newborn bloodspot screening for mucopolysaccharidosis, Type 1 (MPS I)
2025     Adelaide Health Technology Assessment (AHTA) Newborn bloodspot screening for mucopolysaccharidosis Type II (MPS II; Hunter syndrome)
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Naloxone hydrochloride kits - stability and storage]
2025     NIHR Health Technology Assessment programme Implementation and use of technology-enabled remote monitoring for chronic obstructive pulmonary disease: a rapid qualitative evaluation
2025     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of elranatamab (Elrexfio)]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of migraine in adults]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Lipedema]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome in knee replacement revision surgery]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome for implantation of unicondylar sled prosthesis]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome for total knee replacement]